Wei Cao

Title: Wei Cao: Innovator in T Cell Engineering and Cancer Treatment

Introduction

Wei Cao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology, particularly in T cell engineering and cancer treatment. With a total of 3 patents, his work focuses on developing innovative therapies that enhance the efficacy of immune responses against tumors.

Latest Patents

Wei Cao's latest patents include groundbreaking technologies in engineered immune cells. One of his notable inventions is related to compositions and methods for T cell engineering. This patent describes an engineered immune cell that comprises a CAR or engineered TCR, which can enhance the survival and persistence of these cells in vivo, leading to more effective tumor-killing activity. Another significant patent involves CEACAM5-dependent 4-1BB-agonistic bispecific antibodies. These antibodies are designed to treat cancer safely and effectively, providing long-term protective immunological memory against tumors.

Career Highlights

Throughout his career, Wei Cao has worked with notable companies such as Dell Products Inc. and Lanova Medicines Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology and immunotherapy.

Collaborations

Wei Cao has collaborated with talented individuals in his field, including Hao Wang and Nicholas Chun Wei. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Wei Cao is a distinguished inventor whose work in T cell engineering and cancer treatment has the potential to revolutionize immunotherapy. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.